GHS116
Hematoxylin Solution, Gill No. 1
Sign In to View Organizational & Contract Pricing.
Select a Size
Change View
About This Item
form
solution
Quality Level
shelf life
Expiry date on the label.
IVD
for in vitro diagnostic use
concentration
2 g/L
pH
2.5-3.5
application(s)
hematology
histology
storage temp.
room temp
SMILES string
Oc1cc2C[C@@]3(O)COc4c(O)c(O)ccc4[C@H]3c2cc1O
InChI
1S/C16H14O6/c17-10-2-1-8-13-9-4-12(19)11(18)3-7(9)5-16(13,21)6-22-15(8)14(10)20/h1-4,13,17-21H,5-6H2/t13-,16+/m0/s1
InChI key
WZUVPPKBWHMQCE-XJKSGUPXSA-N
Application
Gill No. 1 formulation is used as a progressive cytology stain. Used with hematoxylin and eosin staining.
Other Notes
2 g/L certified hematoxylin
Still not finding the right product?
Explore all of our products under Hematoxylin Solution, Gill No. 1
signalword
Warning
hcodes
Hazard Classifications
Acute Tox. 4 Oral - STOT RE 2 Oral
target_organs
Kidney
Storage Class
10 - Combustible liquids
wgk
WGK 1
flash_point_f
Not applicable
flash_point_c
Not applicable
Choose from one of the most recent versions:
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
Lina Wang et al.
British journal of pharmacology, 178(5), 1055-1072 (2020-12-11)
Macrophage infiltration into the lungs is a characteristic of pulmonary hypertension (PH). Glycolysis is the main metabolic pathway for macrophage activation. However, the effect of macrophage glycolysis on the development of PH remains unknown. We investigated the effect of 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase
Miriam Filippi et al.
Nanoscale, 11(46), 22559-22574 (2019-11-21)
Being crucial under several pathological conditions, tumors, and tissue engineering, the MRI tracing of hypoxia within cells and tissues would be improved by the use of nanosystems allowing for direct recognition of low oxygenation and further treatment-oriented development. In the
Clara Louise Hedegaard et al.
Science advances, 6(40) (2020-10-04)
Bioengineered three-dimensional (3D) matrices expand our experimental repertoire to study tumor growth and progression in a biologically relevant, yet controlled, manner. Here, we used peptide amphiphiles (PAs) to coassemble with and organize extracellular matrix (ECM) proteins producing tunable 3D models